Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Department of Otorhinolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
World Neurosurg. 2022 Feb;158:e451-e458. doi: 10.1016/j.wneu.2021.11.003. Epub 2021 Nov 10.
Sellar reconstruction following endoscopic endonasal surgery (EES) requires modification based on the degree of cerebrospinal fluid (CSF) leak. For high-flow (grade II or III according to Esposito et al. 2007) intraoperative CSF leak, lumbar drainage (LD), in addition to the multilayer closing technique, is generally recommended. However, LD occasionally has complications including postpuncture headache, overdrainage symptoms, and increased length of stay. We retrospectively evaluated the outcome of our graded reconstruction strategy using a multilayer technique with a novel material, without LD, after EES.
Ninety-seven patients who underwent EES with grade II or III intraoperative CSF leak between June 2020 and March 2021 were retrospectively reviewed. For grade II CSF leak, fibrin sealant and a nasoseptal flap were placed; for grade III CSF leak, a multilayer technique was used in combination with collagen matrix, an acellular dermal graft, injectable hydroxyapatite (HXA), and a nasoseptal flap. Postoperatively, routine LD was not performed.
This study included 48 (49.5%) grade II and 49 (50.5%) grade III CSF leaks. At follow-up (mean, 8.7 months), no patient showed postoperative CSF leak in either group. No HXA-associated complications occurred.
A graded surgical repair strategy after EES could avoid postoperative CSF leak. Combined use of injectable HXA and acellular dermal grafts for high-flow CSF leak can limit LD requirement without significant risks.
内镜经鼻蝶入路手术(EES)后鞍底重建需要根据脑脊液(CSF)漏的程度进行修改。对于术中高流量(根据 Esposito 等人,2007 年为 II 级或 III 级)CSF 漏,除了多层封闭技术外,通常建议行腰椎引流(LD)。然而,LD 偶尔会出现并发症,包括穿刺后头痛、过度引流症状和住院时间延长。我们回顾性评估了在 EES 后使用多层技术和新型材料进行分级重建策略的结果,未行 LD。
回顾性分析 2020 年 6 月至 2021 年 3 月期间接受 EES 治疗且术中发生 II 级或 III 级 CSF 漏的 97 例患者。对于 II 级 CSF 漏,使用纤维蛋白胶和鼻中隔瓣;对于 III 级 CSF 漏,采用多层技术联合胶原基质、脱细胞真皮移植物、可注射羟基磷灰石(HXA)和鼻中隔瓣。术后未常规行 LD。
本研究包括 48 例(49.5%)II 级和 49 例(50.5%)III 级 CSF 漏。在随访(平均 8.7 个月)时,两组均无患者出现术后 CSF 漏。未发生与 HXA 相关的并发症。
EES 后分级手术修复策略可避免术后 CSF 漏。对于高流量 CSF 漏,联合使用可注射 HXA 和脱细胞真皮移植物可减少 LD 的需求,而不会增加显著风险。